The proceeds from this round of funding will be used to ramp up doctor first product innovation, enhance the technology stack and scale user acquisition efforts
HealthPlix Technologies has announced the closure of $22million funding in Series C led by Avataar Venture Partners, SIG Venture Capital and existing investors. The funding round marks the first health-tech growth stage investment done by venture capitalists in 2023.
The proceeds from this round of funding will be used to ramp up doctor first product innovation, enhance the technology stack and scale user acquisition efforts.
Sharing his vision, Sandeep Gudibanda, Co-Founder & CEO, HealthPlix Technologies said, “Today, we serve 2.5 per cent of the entire Indian population. With these new funds, we aim to cater to 200-250Mn more patient lives in an 18-month time frame. Avataar Venture Partners and SIG Venture Capital share our passion and the doctor-first ethos, and we are delighted to be partnering with them. We’d be the first health-tech startup in India to secure Series C funding in 2023.”
In 2022, HealthPlix had secured USD 2mn in debt funding from Blacksoil Ventures. The company’s current Series C funding round saw participation from its marquee existing investors, which is a testament to their trust in the health-tech startup.
- Advertisement -